Bladder Cancer
Use
This Fluorescence In Situ Hybridization (FISH) test is designed for detecting chromosomal abnormalities associated with bladder cancer, including aneuploidy of chromosomes 3, 7, and 17, and deletion at the p16 (9p21) locus. It assists in the diagnosis and monitoring of bladder cancer.
Special Instructions
Level of Service: Global or Tech Only. For New York State clients, the test is New York Approved. Specimen must be refrigerated during transport; use cold pack not in direct contact with specimen. Ensure for NYS clients to provide date and time of collection.
Limitations
Not provided.
New York Approved
Methodology
Chromosomal / Cytogenetics (FISH)
Biomarkers
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
33-60 mL voided urine mixed 2:1 with supplied PreservCyt within 30 minutes for total volume 50 mL
Minimum Volume
Not provided
Storage Instructions
Please keep specimen refrigerated until shipment. Use cold pack not in direct contact with specimen.